Atherosclerosis and left ventricular hypertrophy: Persisting problems in treated hypertensive patients

Journal of Hypertension

Volumn 16, Issue 9, 1998, Pages 1389-1395

  Gamble, Greg ^a   MacMahon, Stephen ^a   Culpan, Anne ^a   Ciobo, Colleen ^a   Whalley, Gillian ^a   Sharpe, Norman ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Athersclerosis; Carotid artery; Case control study; Hypertension; Left ventricular mass

Indexed keywords

ANTIHYPERTENSIVE AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; B SCAN; BODY MASS; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; GENERAL PRACTICE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; THICKNESS; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0031678711     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816090-00020     Document Type: Article

References (25)

1. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke and coronary heart disease, Part I: effects of prolonged differences in blood pressure - evidence from nine prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335:765-774.
2. MacMahon S, Rodgers A. The effects of antihypertensive treatment on vascular disease: reappraisal of the evidence in 1994. J Vasc Med Biol 1993; 4:265-271.
3. Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull 1994; 50:272-298.
4. Isles CG, Walker LM, Beevers GD, Brown I, Cameron HL, Clarke HL, et al. Mortality in patients of the Glasgow Blood Pressure Clinic. J Hypertens 1986; 4:141-156.
5. Samuelsson O, Wilhelmsen L, Elmfedt D, Pennert K, Wedel H, Wikstrand J, et al. Predictors of cardiovascular morbidity in treated hypertension: results from the primary preventative trial in Göteborg, Sweden. J Hypertens 1985; 3:167-176.
6. Lindholm L, Ejlertsson G, Schersten B. High risk of cerebro-cardiovascular morbidity in well treated male hypertensives. Acta Med Scand 1984; 216:251-259,
7. Wilson PWF, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality: the Framingham Heart Study. Arteriosclerosis 1988; 8:737-741.
8. MacMahon SW, Macdonald GJ, Blacket RB. Plasma lipoprotein levels in treated and untreated hypertensive men and women. The National Heart Foundation of Australia Risk Factor Prevalence Study. Arteriosclerosis 1985; 5:391-396.
9. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37:1595-1606.
10. Gamble G, Beaumont B, Smith H, Zorn J, Sanders G, Merrilees M, et al. B-mode ultrasound images of the carotid artery wall: correlation of ultrasound with histological measurements. Atherosclerosis 1993; 102:163-173.
11. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man, anatomic validation of the method. Circulation 1977; 55:613-618.
12. Hammond I, Deveruex R, Alderman M, Lutas E, Spitzer M, Crowley J, et al. The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol 1986; 7:639-650.
13. Liao Y, Cooper R, Mensah G, McGee D. Left ventricular hypertrophy has a greater impact on survival in women than in men. Circulation 1995; 92:805-810.
14. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1:307-310.
15. SAS Institute Inc. SAS/STAT Guide for Personal Computers. Cary, NC: SAS Institute Inc; 1987.
16. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb Vasc Biol 1991; 11:1245-1249.
17. Levy D, Garrison R, Savage D, Kannel W, Castelli W. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561-1566.
18. MacMahon SW, MacDonald GJ, Bernstein L, Andrews G, Blacket RB. Comparison of weight reduction with metoprolol in treatment of hypertension in young overweight patients. Lancet 1985; i:1233-1236.
19. MacMahon S, Cutler J, Brittain E, Higgins M. Obesity and hypertension: epidemiological and clinical issues. Eur Heart J 1987; 8 (suppl B):57-70.
20. Jones DW. Body weight and blood pressure: effects of weight reduction on hypertension. Am J Hypertens 1996; 9 (suppl):50s-54s.
21. Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? III. Analysis of data from trials of salt reduction. BMJ 1991; 302:819-824.
22. Katzel LI, Bleecker ER, Colman EG, Rogus EM, Sorkin JD, Goldberg AP. Effects of weight loss vs aerobic exercise training on risk factors for coronary disease in healthy, obese, middle-aged and older men: a randomized controlled trial. JAMA 1995; 274:1915-1921.
23. Wing RR, Jeffery RW. Effect of modest weight loss on changes in cardiovascular risk factors: are there differences between men and women or between weight loss and maintenance? Int J Obes Relat Metab Disord 1995; 19:67-73.
24. MacMahon SW, Wilcken DEL, MacDonald GJ. The effect of weight reduction on left ventricular mass: a randomized controlled trial in young, overweight hypertensive patients. N Engl J Med 1986; 314:334-339.
25. Himeno E, Nishino K, Nakashima Y, Kuroiwa A, Ikeda M. Weight reduction regresses left ventricular mass regardless of blood pressure level in obese subjects. Am Heart J 1996; 131:313-319.